PHEX and hypophosphatemia: In the hypophosphatemia genetic testing program, approximately 10% of clinically confirmed XLH patients had no variant identified in PHEX or in another gene, suggesting that up to 10% of clinical XLH patients may have an undetected PHEX variant (Rush et al., 2021).